Status:
COMPLETED
To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.
Lead Sponsor:
GlaxoSmithKline
Conditions:
Depressive Disorder and Anxiety Disorders
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
A study to investigate the effects GSK561679 on part of the body's system that controls the balance of many of the hormones (including cortisol).
Eligibility Criteria
Inclusion
- Inclusion:
- Healthy male subjects
- non-smoker
- normal ECG
- Exclusion:
- shift workers
- vegetarians
- persons who travel distances
- persons participating in a psychology or psychiatry course
Exclusion
Key Trial Info
Start Date :
October 6 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 8 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00426608
Start Date
October 6 2006
End Date
January 8 2007
Last Update
September 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ